A meta-analysis of anti-interleukin-13 monoclonal antibodies for uncontrolled asthma

More and more clinical trials have tried to assess the clinical benefit of anti-interleukin (IL)-13 monoclonal antibodies for uncontrolled asthma. The aim of this study is to evaluate the efficacy and safety of anti-IL-13 monoclonal antibodies for uncontrolled asthma. Major databases were searched f...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Hang, Wang, Kai, Huang, Huiting, Cheng, Wenbin, Liu, Xiaohong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6355027/
https://www.ncbi.nlm.nih.gov/pubmed/30703143
http://dx.doi.org/10.1371/journal.pone.0211790

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6355027/
https://www.ncbi.nlm.nih.gov/pubmed/30703143
http://dx.doi.org/10.1371/journal.pone.0211790

Ejemplares similares